Your browser doesn't support javascript.
loading
Further delineation of the rare GDACCF (global developmental delay, absent or hypoplastic corpus callosum, dysmorphic facies syndrome): genotype and phenotype of 22 patients with ZNF148 mutations.
Szakszon, Katalin; Lourenco, Charles Marques; Callewaert, Bert Louis; Geneviève, David; Rouxel, Flavien; Morin, Denis; Denommé-Pichon, Anne-Sophie; Vitobello, Antonio; Patterson, Wesley G; Louie, Raymond; Pinto E Vairo, Filippo; Klee, Eric; Kaiwar, Charu; Gavrilova, Ralitza H; Agre, Katherine E; Jacquemont, Sebastien; Khadijé, Jizi; Giltay, Jacques; van Gassen, Koen; Mero, Gabriella; Gerkes, Erica; Van Bon, Bregje W; Rinne, Tuula; Pfundt, Rolph; Brunner, Han G; Caluseriu, Oana; Grasshoff, Ute; Kehrer, Martin; Haack, Tobias B; Khelifa, Melik Malek; Bergmann, Anke Katharina; Cueto-González, Anna Maria; Martorell, Ariadna Campos; Ramachandrappa, Shwetha; Sawyer, Lindsey B; Fasel, Pascale; Braun, Dominique; Isis, Atallah; Superti-Furga, Andrea; McNiven, Vanda; Chitayat, David; Ahmed, Syed Anas; Brennenstuhl, Heiko; Schwaibolf, Eva Mc; Battisti, Gladys; Parmentier, Benoit; Stevens, Servi J C.
Afiliação
  • Szakszon K; Faculty of Medicine Institute of Pediatrics, University of Debrecen, Debrecen, Hungary szakszon.katalin@med.unideb.hu.
  • Lourenco CM; Rare Congenital Malformations and Rare intellectual Disability (ERN ITHACA), European Reference Networks, Debrecen, Hungary.
  • Callewaert BL; Neurogenetics Unit - Inborn Errors of Metabolism Clinics, National Reference Center for Rare Diseases, Medicine School of Sao Jose do Rio Preto, Sao Jose do Rio Preto, Brazil.
  • Geneviève D; Center for Medical Genetics, University Hospital Ghent, Gent, Belgium.
  • Rouxel F; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Morin D; Montpellier University, Inserm Unit U1183, Reference Center for Rare Disease: Developmental Anomalies. Clinical Genetic Unit, CHU Montpellier, Montpellier, France.
  • Denommé-Pichon AS; Rare Congenital Malformations and Rare Intellectual Disability (ERN ITHACA), European Reference Networks, Montpellier, France.
  • Vitobello A; Génétique Clinique, Départment de Génétique Médicale, Maladies Rares et Médecine Personnalisée, CHU Montpellier, Montpellier University, Centre de Référence Anomalies du Développement SOOR, Montpellier, France.
  • Patterson WG; Rare Kidney Disease Center, Montpellier University Hospital, Montpellier, France.
  • Louie R; Functional Unity of Innovative Diagnosis for Rare Diseases, University of Burgundy, Dijon, France.
  • Pinto E Vairo F; Inserm UMR1231 team GAD, University of Burgundy, Dijon, France.
  • Klee E; Functional Unity of Innovative Diagnosis for Rare Diseases, University of Burgundy, Dijon, France.
  • Kaiwar C; Inserm UMR1231 team GAD, University of Burgundy, Dijon, France.
  • Gavrilova RH; Greenwood Genetic Center Foundation, Greenwood, South Carolina, USA.
  • Agre KE; Greenwood Genetic Center Inc, Greenwood, South Carolina, USA.
  • Jacquemont S; Department of Clinical Genomics, Center for Individualized Medicine, Mayo Clinic Research Rochester, Rochester, Minnesota, USA.
  • Khadijé J; Department of Clinical Genomics, Center for Individualized Medicine, Mayo Clinic Research Rochester, Rochester, Minnesota, USA.
  • Giltay J; Department of Clinical Genomics, Center for Individualized Medicine, Mayo Clinic Research Rochester, Rochester, Minnesota, USA.
  • van Gassen K; Department of Clinical Genomics, Center for Individualized Medicine, Mayo Clinic Research Rochester, Rochester, Minnesota, USA.
  • Mero G; Department of Clinical Genomics, Center for Individualized Medicine, Mayo Clinic Research Rochester, Rochester, Minnesota, USA.
  • Gerkes E; Sainte-Justine Research Center, Sainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada.
  • Van Bon BW; Department of Medical Genetics, Sainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada.
  • Rinne T; Department of Medical Genetics, Sainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada.
  • Pfundt R; Department of Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Brunner HG; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Caluseriu O; Faculty of Medicine Institute of Pediatrics, University of Debrecen, Debrecen, Hungary.
  • Grasshoff U; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
  • Kehrer M; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Haack TB; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Khelifa MM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Bergmann AK; Klinische Genetica, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Cueto-González AM; Medical Genetics Clinic, University of Alberta, Edmonton, Alberta, Canada.
  • Martorell AC; Institute of Medical Genetics and Applied Genomics, University Clinic, Tübingen University, Tübingen, Germany.
  • Ramachandrappa S; Institute of Medical Genetics and Applied Genomics, University Clinic, Tübingen University, Tübingen, Germany.
  • Sawyer LB; Institute of Medical Genetics and Applied Genomics, University Clinic, Tübingen University, Tübingen, Germany.
  • Fasel P; Department of Human Genetics, Medical College Hannover, Hannover, Germany.
  • Braun D; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Isis A; Department of Clinical and Molecular Genetics, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Superti-Furga A; Rare Congenital Malformations and Rare intellectual Disability (ERN ITHACA), European Reference Networks, Barcelona, Spain.
  • McNiven V; Pediatric Endocrinology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Chitayat D; Endocrinology Group, Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Vall d'Hebron Research Institute, Barcelona, Spain.
  • Ahmed SA; Clinical Genetics Department, Guy's & St Thomas' NHS Foundation Trust, London, UK.
  • Brennenstuhl H; Department of Medical Genetics, Children's Hospital of The King's Daughters, Norfolk, Virginia, USA.
  • Schwaibolf EM; Department of Human Genetics, Inselspital Bern, University of Bern, Bern, Switzerland.
  • Battisti G; Department of Human Genetics, Inselspital Bern, University of Bern, Bern, Switzerland.
  • Parmentier B; Division of Genetic Medicine, Lausanne University Hospital, Lausanne, Switzerland.
  • Stevens SJC; Division of Genetic Medicine, Lausanne University Hospital, Lausanne, Switzerland.
J Med Genet ; 61(2): 132-141, 2024 Jan 19.
Article em En | MEDLINE | ID: mdl-37580113
BACKGROUND: Pathogenic variants in the zinc finger protein coding genes are rare causes of intellectual disability and congenital malformations. Mutations in the ZNF148 gene causing GDACCF syndrome (global developmental delay, absent or hypoplastic corpus callosum, dysmorphic facies; MIM #617260) have been reported in five individuals so far. METHODS: As a result of an international collaboration using GeneMatcher Phenome Central Repository and personal communications, here we describe the clinical and molecular genetic characteristics of 22 previously unreported individuals. RESULTS: The core clinical phenotype is characterised by developmental delay particularly in the domain of speech development, postnatal growth retardation, microcephaly and facial dysmorphism. Corpus callosum abnormalities appear less frequently than suggested by previous observations. The identified mutations concerned nonsense or frameshift variants that were mainly located in the last exon of the ZNF148 gene. Heterozygous deletion including the entire ZNF148 gene was found in only one case. Most mutations occurred de novo, but were inherited from an affected parent in two families. CONCLUSION: The GDACCF syndrome is clinically diverse, and a genotype-first approach, that is, exome sequencing is recommended for establishing a genetic diagnosis rather than a phenotype-first approach. However, the syndrome may be suspected based on some recurrent, recognisable features. Corpus callosum anomalies were not as constant as previously suggested, we therefore recommend to replace the term 'GDACCF syndrome' with 'ZNF148-related neurodevelopmental disorder'.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucoencefalopatias / Deficiência Intelectual Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucoencefalopatias / Deficiência Intelectual Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article